The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
KRYS · Healthcare · Narrow moat
On the watchlist
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | SOLV | USPH | ANIP | KRYS |
|---|---|---|---|---|
| Moat Score (0–100) | 62 (highest) | 62 (highest) | 62 (highest) | 62 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 64 | 55 | 80 | 100 (highest) |
| Pricing power | 94 (highest) | 35 | 94 (highest) | — |
| Returns on capital | 38 | 68 (highest) | 14 | 4 |
| Balance-sheet safety | 79 | 84 | 57 | 100 (highest) |
| Capital allocation | 37 | 70 (highest) | 67 | 44 |
| 26% below value if growth stopped today (largest discount to value if growth stopped today) | No price data | 377% above value if growth stopped today | 7956% above value if growth stopped today | |
| Market cap | $13.5B | Not reported | $1.7B | $9.8B |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |